Document Classification

Section Type: RESULTS

Text: The efficacy of the two treatment groups was similar in terms of the maintenance of blood glucose levels (fasting blood glucose, p-value is 0. 10 ; postprandial blood glucose, p-value is 0. 95 ; glycosylated haemoglobin, p-value is 0. 30) and the effect on blood pressure (systolic blood pressure, p-value is 0. 45 ; diastolic blood pressure, p-value is 0. 95), while the pioglitazone group showed significantly better efficacy in improving the lipid profile compared to the rosiglitazone group (total cholesterol, p-value is 0. 002 ; triglycerides, p-value is 0. 002 ; low density lipoprotein, p-value is 0. 005 ; and high density lipoprotein, p-value is 0. 43).